Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-11 | New | $4,350,000 | $4,350,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| George Daaboul | Director, Executive |
| David Freedman | Director, Executive |
| Paul Meister | Director |
| Vinit Nijhawan | Director |
| David Walt | Director |